Diversification is a Good Thing | GenomeWeb

Daniel MacArthur follows up on Steven Pinker's NYT story about having his genome sequenced with a blog post on the diversification of consumer genomics. All four of the current consumer genomics companies have staked their claim, with 23andMe focusing on fun, deCodeMe on academics, Navigenics on medical accuracy, and Knome on boutique offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.